Manesh R. Patel Journalist Profile

Articles

AF Symposium 25: LAA Closure Vs Oral Anticoagulation After Catheter Ablation for AF: Concomitant and Sequential Cohorts of OPTION

Jan 20, 2025 | arrhythmiaacademy.com | Gi-Byoung Nam |Walid Saliba |Oussama Wazni |Manesh R. Patel

AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.
Patient Case No. 2

Jan 8, 2025 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoJanuary 8, 2025Author(s):, Difficult-to-treat hypertension involves uncontrolled blood pressure despite using three or more antihypertensive medications, including a diuretic. It is distinct from resistant hypertension, which is more common and may not include a diuretic in treatment. This condition affects a smaller subset of patients with high blood pressure and requires a comprehensive management approach.
Patient Case No. 2

Jan 8, 2025 | consultantlive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

Advancing Hypertension Management: Unmet Needs, Endothelial Dysfunction, and CKD Therapies - Episode 11Published on: , , , Panelists discuss how chronic kidney disease (CKD) and uncontrolled hypertension create a damaging cycle, in which hypertension accelerates kidney damage while declining kidney function makes blood pressure harder to control. Patient No. 2 has stage 3 CKD and uncontrolled hypertension.
Difficult-to-Treat Hypertension Treatment Strategies

Dec 11, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 11, 2024Author(s):, Difficult-to-treat hypertension involves uncontrolled blood pressure despite using three or more antihypertensive medications, including a diuretic. It is distinct from resistant hypertension, which is more common and may not include a diuretic in treatment. This condition affects a smaller subset of patients with high blood pressure and requires a comprehensive management approach.
Drug Classes Available to Treat Patients With High Blood Pressure

Dec 11, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 11, 2024Author(s):, Antihypertensive drug classes include diuretics, beta-blockers, ACE inhibitors, ARBs, calcium channel blockers, and alpha-blockers, each with distinct mechanisms of action targeting blood pressure regulation. Diuretics reduce blood volume, beta-blockers decrease heart rate, ACE inhibitors and ARBs inhibit the renin-angiotensin-aldosterone system, and calcium channel blockers relax blood vessels.
Does STEMI Need a Rebrand to ‘Occlusion MI’?

Dec 10, 2024 | medscape.com | Robert Harrington |Manesh R. Patel |C. Michael Gibson

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published. Manage Email Alerts
Current Limitations With Traditional Antihypertensive Drugs

Dec 4, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 4, 2024Author(s):, Traditional antihypertensive drugs often result in variable patient responses and side effects, complicating treatment efficacy and patient adherence. Lifelong administration of these medications can lead to compliance issues, impacting long-term management of hypertension. Current treatments primarily manage symptoms rather than addressing the underlying pathophysiology of hypertension.
Current Limitations With Traditional Antihypertensive Drugs

Dec 4, 2024 | consultantlive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

Advancing Hypertension Management: Unmet Needs, Endothelial Dysfunction, and CKD Therapies - Episode 2Current Limitations With Traditional Antihypertensive DrugsPublished on: December 4, 2024Manesh R. Patel, MD, Payal Kohli, MD, FACC, John M. Flack, MD, MPH, FASH, C.
Unmet Needs in HTN: Patient Adherence, Comorbid Conditions, and Prevalence

Dec 4, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 4, 2024Author(s):, Patient adherence to antihypertensive regimens is crucial for effective blood pressure control, with non-adherence leading to suboptimal outcomes and increased health risks. Comorbid conditions like CKD complicate hypertension management, requiring tailored therapeutic approaches and careful monitoring to achieve optimal blood pressure control.
Translating AI for the Clinician

Oct 15, 2024 | jamanetwork.com | Manesh R. Patel |Michael J. Pencina

Translating AI for the Clinician Testing and Evaluation of Health Care Applications of Large Language Models Suhana Bedi, BA; Yutong Liu, MA; Lucy Orr-Ewing, BA; Dev Dash, MD, MPH; Sanmi Koyejo, PhD; Alison Callahan, PhD; Jason A. Fries, PhD; Michael Wornow, BA; Akshay Swaminathan, BA; Lisa Soleymani Lehmann, MD, PhD; Hyo Jung Hong, MD; Mehr Kashyap, MD; Akash R. Chaurasia, MS; Nirav R.